Emmaus Life Sciences Announces Presentation of Abstract at the 2018 American Society of Hematology Annual Meeting Nov 02, 2018 4:15pm EDT
Emmaus Life Sciences, a Leader in Sickle Cell Disease Treatment, to Sponsor the 12th Annual Sickle Cell Disease and Thalassaemia (ASCAT) Conference in London Oct 22, 2018 12:25pm EDT
Emmaus Life Sciences, a Leader in Sickle Cell Disease Treatment, to Sponsor the 46th Annual National Sickle Cell Disease Association of America Convention in Baltimore Oct 09, 2018 11:15am EDT
Emmaus Life Sciences to Participate in the Cantor Global Healthcare Conference Oct 02, 2018 10:26am EDT
Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari™ (L-glutamine oral powder) Sep 19, 2018 9:01am EDT
Emmaus Life Sciences, a Leader in Sickle Cell Disease Treatment, to Present at the Seventh Annual Sickle Cell Disease Therapeutics Conference in New York City on September 13th Sep 11, 2018 2:03pm EDT
Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with McKesson to Expand Distribution Network for Endari™ (L-glutamine oral powder) Aug 27, 2018 8:18am EDT
Emmaus Life Sciences Partners with DMS Pharmaceutical Group to Provide Endari™ (L-glutamine oral powder) to Military Personnel and Beneficiaries for Treatment of Sickle Cell Disease Jul 30, 2018 8:30am EDT
Emmaus Life Sciences Strengthens its Finance & Operations Leadership to Support Commercialization of Endari™ Jul 25, 2018 8:36am EDT
